Skip to main content

Status of COVID-19 Pandemic Before the Administration of Vaccine

  • Protocol
  • First Online:
Vaccine Design

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2410))

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the disease COVID-19 that has decimated the health and economy of our planet. The virus causes the disease not only in people but also in companion and wild animals. As yet we do not know why the virus is highly successful in causing the pandemic within 3 months of its first report. Lack of a voice on how to handle the pandemic impacted the management of the disease globally. Publication of the importance of masks and social distancing in preprint servers reduced the spread of the disease and deaths associated with it. Very few countries have invested in science and research and development and that has impacted the development of therapies for the pandemic. Though vaccination against COVID-19 started in December 2020, slower rate of immunizations has resulted in rapid spread of the mutant strains of SARS-CoV-2. Lack of transparency and accountability coupled with anergic leadership was responsible for the high incidence of disease and death associated with the COVID-19 pandemic.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Change history

  • 01 January 2022

    A correction has been published.

References

  1. Yang X, Zhao J, Yan Q, Zhang S, Wang Y, Li Y (2020) A case of COVID-19 patient with the diarrhea as initial symptom and literature review. Clin Res Hepatol Gastroenterol 44(5):e109–e112

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Effenberger M, Grabherr F, Mayr L, Schwaerzler J, Nairz M, Seifert M, Hilbe R, Seiwald S, Scholl-Buergi S, Fritsche G, Bellmann-Weiler R, Weiss G, Müller T, Adolph TE, Tilg H (2020) Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut 69:1543–1544

    Article  CAS  PubMed  Google Scholar 

  3. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M (2020) Presumed asymptomatic carrier transmission of COVID-19. JAMA 323:1406–1407

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Gao Z, Xu Y, Sun C et al (2020) A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect 54:12–16

    Article  PubMed  PubMed Central  Google Scholar 

  5. Thomas S (2020) The structure of the membrane protein of SARS-CoV-2 resembles the sugar transporter SemiSWEET. Pathog Immun 5(1):342–363

    Article  PubMed  PubMed Central  Google Scholar 

  6. Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, Li SB, Wang HY, Zhang S, Gao HN, Sheng JF, Cai HL, Qiu YQ, Li LJ (2020) Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 368:m606

    Article  PubMed  PubMed Central  Google Scholar 

  7. Green A (2020) Li Wenliang. Lancet 395:682

    Article  CAS  PubMed Central  Google Scholar 

  8. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrobial Agents 55:105924

    Article  CAS  Google Scholar 

  9. Zhang C, Zheng W, Huang X, Bell EW, Zhou X, Zhang Y (2020) Protein structure and sequence reanalysis of 2019-nCoV genome refutes snakes as its intermediate host and the unique similarity between its spike protein insertions and HIV-1. J Proteome Res 19:1351–1360

    Article  CAS  PubMed  Google Scholar 

  10. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270–273

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Liu P, Jiang J-Z, Wan X-F, Hua Y, Li L, Zhou J et al (2020) Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? PLoS Pathog 16(5):e1008421

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Xiao K, Zhai J, Feng Y, Zhou N, Zhang X, Zou JJ, Li N, Guo Y, Li X, Shen X, Zhang Z, Shu F, Huang W, Li Y, Zhang Z, Chen RA, Wu YJ, Peng SM, Huang M, Xie WJ, Cai QH, Hou FH, Chen W, Xiao L, Shen Y (2020) Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins. Nature 583:286–289

    Article  CAS  PubMed  Google Scholar 

  13. Oude Munnink BB, Sikkema RS, Nieuwenhuijse DF, Molenaar RJ, Munger E, Molenkamp R, van der Spek A, Tolsma P, Rietveld A, Brouwer M, Bouwmeester-Vincken N, Harders F, Hakze-van der Honing R, Wegdam-Blans MCA, Bouwstra RJ, GeurtsvanKessel C, van der Eijk AA, Velkers FC, Smit LAM, Stegeman A, van der Poel WHM, Koopmans MPG (2021) Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans. Science 371:172–177

    Article  CAS  PubMed  Google Scholar 

  14. McAloose D, Laverack M, Wang L, Killian ML, Caserta LC, Yuan F, Mitchell PK, Queen K, Mauldin MR, Cronk BD, Bartlett SL, Sykes JM, Zec S, Stokol T, Ingerman K, Delaney MA, Fredrickson R, Ivančić M, Jenkins-Moore M, Mozingo K, Franzen K, Bergeson NH, Goodman L, Wang H, Fang Y, Olmstead C, McCann C, Thomas P, Goodrich E, Elvinger F, Smith DC, Tong S, Slavinski S, Calle PP, Terio K, Torchetti MK, Diel DG (2020) From people to Panthera: natural SARS-CoV-2 infection in tigers and lions at the Bronx zoo. mBio 11(5):e02220-20

    Article  PubMed  PubMed Central  Google Scholar 

  15. Sia SF, Yan LM, Chin AWH, Fung K, Choy KT, Wong AYL et al (2020) Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature 583:834–838

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Shi J, Wen Z, Zhong G, Yang H, Wang C, Huang B et al (2020) Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science 368:1016–1020

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Wang Z, Fu Y, Guo Z, Li J, Li J, Cheng H, Lu B, Sun Q (2020) Transmission and prevention of SARS-CoV-2. Biochem Soc Trans 48(5):2307–2316

    Article  CAS  PubMed  Google Scholar 

  18. Xu Y, Li X, Zhu B, Liang H, Fang C, Gong Y, Guo Q, Sun X, Zhao D, Shen J, Zhang H, Liu H, Xia H, Tang J, Zhang K, Gong S (2020) Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med 26(4):502–505

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI, Ravelli RBG, Paul van Schayck J, Mykytyn AZ, Duimel HQ, van Donselaar E, Riesebosch S, Kuijpers HJH, Schipper D, van de Wetering WJ, de Graaf M, Koopmans M, Cuppen E, Peters PJ, Haagmans BL, Clevers H (2020) SARS-CoV-2 productively infects human gut enterocytes. Science 369:50–54

    Article  CAS  PubMed  Google Scholar 

  20. Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MMG, Spijker R, Hooft L, Emperador D, Dittrich S, Domen J, Horn SRA, Van den Bruel A (2020) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst Rev 7:CD013665

    PubMed  Google Scholar 

  21. Caballero AE, Ceriello A, Misra A, Aschner P, McDonnell ME, Hassanein M, Ji L, Mbanya JC, Fonseca VA (2020) COVID-19 in people living with diabetes: an international consensus. J Diabetes Complicat 34:107671

    Article  CAS  Google Scholar 

  22. Huang I, Lim MA, Pranata R (2020) Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr 14:395–403

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ceriello A (2020) Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory. Diabetes Res Clin Pract 163:108186

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Yan Y, Yang Y, Wang F, Ren H, Zhang S, Shi X, Yu X, Dong K (2020) Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ Open Diabetes Res Care 8(1):e001343

    Article  PubMed  Google Scholar 

  25. Chen J, Wu C, Wang X, Yu J, Sun Z (2020) The impact of COVID-19 on blood glucose: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 11:574541

    Article  Google Scholar 

  26. Peters MC, Sajuthi S, Deford P, Christenson S, Rios CL, Montgomery MT et al (2020) COVID-19 related genes in sputum cells in asthma: relationship to demographic features and corticosteroids. Am J Respir Crit Care Med 202:83–90

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z (2020) ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol 18:2128–2130.e2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Mallapaty S (2020) Mounting clues suggest the coronavirus might trigger diabetes. Nature 583:16–17

    Article  CAS  PubMed  Google Scholar 

  29. Zhang Y, Li H, Zhang J, Cao Y, Zhao X, Yu N et al (2020) The clinical characteristics and outcomes of diabetes mellitus and secondary hyperglycemia patients with coronavirus disease 2019: a single-center, retrospective, observational study in Wuhan. Diabetes Obes Metab 22:1443–1454

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Jiang B, Wei H (2020) Oxygen therapy strategies and techniques to treat hypoxia in COVID-19 patients. Eur Rev Med Pharmacol Sci 24:10239–10246

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Liu L, Cai D, Huang X, Shen Y (2021) COVID-2019 associated with acquired monocular blindness. Curr Eye Res 3:1–4

    Google Scholar 

  32. Centers for Disease Control and Prevention (2021) Fungal diseases. About mucormycosis. Retrieved from: https://www.cdc.gov/fungal/diseases/mucormycosis/definition.html

  33. Sharma S, Grover M, Bhargava S, Samdani S, Kataria T (2021) Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Otol 8:1–6

    Google Scholar 

  34. Centers for Disease Control and Prevention (2021) Fungal diseases and Covid-19. Retrieved from: https://www.cdc.gov/fungal/covid-fungal.html

  35. Villanueva-Lozano H, Treviño-Rangel RJ, González GM, Ramírez-Elizondo MT, Lara-Medrano R, Aleman-Bocanegra MC, Guajardo-Lara CE, Gaona-Chávez N, Castilleja-Leal F, Torre-Amione G, Martínez-Reséndez MF (2021) Outbreak of Candida auris infection in a COVID-19 hospital in Mexico. Clin Microbiol Infect 27:813–816

    Article  CAS  PubMed Central  Google Scholar 

  36. Brian DA, Baric RS (2005) Coronavirus genome structure and replication. Curr Top Microbiol Immunol 287:1–30

    CAS  PubMed  Google Scholar 

  37. Thomas S (2021) Mapping the non-structural transmembrane proteins of SARS-CoV-2. J Comp Biol 28:909–921

    Google Scholar 

  38. Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, Graham BS, Mc-Lellan JS (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367:1260–1263

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Amraie R, Napoleon MA, Yin W et al (2020) CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells. Preprint. bioRxiv 2020;2020.06.22.165803

    Google Scholar 

  40. Belov GA, van Kuppeveld FJ (2012) (+)RNA viruses rewire cellular pathways to build replication organelles. Curr Opin Virol 2(6):740–747

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Ghosh AK, Brindisi M, Shahabi D, Chapman ME, Mesecar AD (2020) Drug development and medicinal chemistry efforts toward SARS-coronavirus and Covid-19 therapeutics. Chem Med Chem 15:907–932

    Article  CAS  PubMed  Google Scholar 

  42. Centers for Disease Control and Prevention (2021) Emerging SARS-CoV-2 variants. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/scientific-brief-emerging-variants.html

  43. Zhang W, Davis BD, Chen SS, Sincuir Martinez JM, Plummer JT, Vail E (2021) Emergence of a novel SARS-CoV-2 variant in Southern California. JAMA 325:1324–1326

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Edara VV, Lai L, Sahoo MK, Floyd K, Sibai M, Solis D, Flowers MW, Hussaini L, Ciric CR, Bechnack S, Stephens K, Mokhtari EB, Mudvari P, Creanga A, Pegu A, Derrien-Colemyn A, Henry AR, Gagne M, Graham BS, Wrammert J, Douek DC, Boritz E, Pinsky BA, Suthar MS (2021) Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant. bioRxiv (Preprint). 2021.05.09.443299

    Google Scholar 

  45. New York Times (2020). Retrieved from https://www.nytimes.com/2020/03/29/world/asia/coronavirus-india-migrants.html

  46. Codo AC, Davanzo GG, Monteiro LB, de Souza GF, Muraro SP, Virgilio-da-Silva JV, Prodonoff JS, Carregari VC, de Biagi Junior CAO, Crunfli F, Jimenez Restrepo JL, Vendramini PH, Reis-de-Oliveira G, Bispo Dos Santos K, Toledo-Teixeira DA, Parise PL, Martini MC, Marques RE, Carmo HR, Borin A, Coimbra LD, Boldrini VO, Brunetti NS, Vieira AS, Mansour E, Ulaf RG, Bernardes AF, Nunes TA, Ribeiro LC, Palma AC, Agrela MV, Moretti ML, Sposito AC, Pereira FB, Velloso LA, Vinolo MAR, Damasio A, Proença-Módena JL, Carvalho RF, Mori MA, Martins-de-Souza D, Nakaya HI, Farias AS, Moraes-Vieira PM (2020) Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis. Cell Metab 32:437–446.e5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Ngonghala CN, Iboi E, Eikenberry S, Scotch M, MacIntyre CR, Bonds MH, Gumel AB (2020) Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel coronavirus. Math Biosci 325:108364

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Howard J, Huang A, Li Z, Tufekci Z, Zdimal V, van der Westhuizen HM, von Delft A, Price A, Fridman L, Tang LH, Tang V, Watson GL, Bax CE, Shaikh R, Questier F, Hernandez D, Chu LF, Ramirez CM, Rimoin AW (2021) An evidence review of face masks against COVID-19. Proc Natl Acad Sci U S A 118:e2014564118

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ (2020) COVID-19 systematic urgent review group effort (SURGE) study authors. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta–analysis. Lancet 395:1973–1987

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. CNBC (2021). Retrieved from https://www.cnbc.com/2021/02/26/israeli-data-suggest-mass-vaccinations-led-to-drop-in-severe-covid-cases-cdc-study-finds.html

  51. Moutinho S (2021) Syringe size and supply issues continue to waste COVID-19 vaccine doses in United States. Retrieved from: https://www.sciencemag.org/news/2021/03/syringe-size-and-supply-issues-continue-waste-covid-19-vaccine-doses-united-states

  52. Olsen SJ, Azziz-Baumgartner E, Budd AP et al (2020) Decreased influenza activity during the COVID-19 pandemic — United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep 69:1305–1309

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Thomas, S. (2022). Status of COVID-19 Pandemic Before the Administration of Vaccine. In: Thomas, S. (eds) Vaccine Design. Methods in Molecular Biology, vol 2410. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1884-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-1884-4_4

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-1883-7

  • Online ISBN: 978-1-0716-1884-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics